1159 studies found for:    "Embolism and Thrombosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
2 Completed Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Conditions: Arrhythmia;   Atrial Fibrillation;   Cardiovascular Diseases;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Heart Diseases;   Thrombophlebitis;   Cerebrovascular Accident
Intervention: Drug: warfarin
3 Completed Stroke Prevention in Sickle Cell Anemia (STOP 1)
Conditions: Anemia, Sickle Cell;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Hematologic Diseases;   Hemoglobinopathies
Intervention: Procedure: blood transfusion
4 Completed Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Conditions: Blood Disease;   Anemia, Sickle Cell;   Cerebrovascular Disorders;   Cerebral Embolism and Thrombosis
Intervention:
5 Unknown  Registry of AngioJet Use in the Peripheral Vascular System
Conditions: Peripheral Vascular Disease;   Embolism and Thrombosis;   Venous Thrombosis
Intervention:
6 Completed
Has Results
Epidemiology of Thromboembolism Disease: A Cohort Study
Conditions: Vascular Diseases;   Embolism and Thrombosis;   Phlebitis;   Venous Insufficiency;   Pulmonary Embolism
Intervention: Other: procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis
7 Completed Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
Conditions: Venous Thromboembolism;   Embolism and Thrombosis;   Hip Fractures
Intervention: Drug: TTP889
8 Completed The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
Condition: Embolism and Thrombosis
Interventions: Drug: Dalteparin;   Drug: Warfarin
9 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Conditions: Embolism and Thrombosis;   Embolism;   Vascular Diseases;   Warfarin;   Venous Thromboembolism;   Thrombosis;   Thromboembolism
Intervention: Other: CYP 2C9 and VKORC1 Testing for Warfarin
10 Completed A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Anticoagulants;   Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Enoxaparin Sodium;   Embolism and Thrombosis;   Deep Vein Thrombosis;   DU-176b;   Edoxaban;   Factor Xa;   Oral;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176V 15 mg tablets oral, once daily for 2 weeks;   Drug: DU-176b 30 mg tablets, oral once daily for 2 weeks;   Drug: Enoxaparin sodium 20 mg (=2000IU) / 0.2ml twice daily, subcutaneous
11 Unknown  Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion
Conditions: Intracranial Embolism;   Thrombosis
Intervention: Procedure: transcranial ultrasound in patients treated with iv t-PA
12 Completed A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Conditions: Prevention;   Venous Thromboembolism
Interventions: Drug: edoxaban;   Drug: enoxaparin sodium
13 Active, not recruiting Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
14 Completed A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
Condition: Thromboembolism
Interventions: Drug: Certoparin;   Drug: Unfractionated Heparin
15 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
16 Not yet recruiting Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
17 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
18 Terminated Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy
Conditions: Intracranial Embolism;   Cerebral Thromboembolism;   Carotid Stenosis
Interventions: Drug: ARC1779 Injection;   Drug: Placebo (normal saline)
19 Completed Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in Neonates
Condition: Intracranial Thrombosis
Intervention: Procedure: Ultrasound
20 Completed
Has Results
Evaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC)
Condition: Atrial Fibrillation
Intervention: Other: Magnetic Resonance Imaging (MRI)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years